sajazir
Generic: icatibant
Labeler: cycle pharmaceuticals ltd-ukDrug Facts
Product Profile
Brand Name
sajazir
Generic Name
icatibant
Labeler
cycle pharmaceuticals ltd-uk
Dosage Form
INJECTION
Routes
Active Ingredients
icatibant acetate 30 mg/3mL
Manufacturer
Identifiers & Regulatory
Product NDC
70709-013
Product ID
70709-013_98f58ca8-04a0-4453-adf0-b000d3bcfae1
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA212446
Listing Expiration
2026-12-31
Marketing Start
2021-06-03
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
70709013
Hyphenated Format
70709-013
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
sajazir (source: ndc)
Generic Name
icatibant (source: ndc)
Application Number
ANDA212446 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 30 mg/3mL
Packaging
- 1 SYRINGE, GLASS in 1 CARTON (70709-013-01) / 3 mL in 1 SYRINGE, GLASS
- 3 SYRINGE, GLASS in 1 CARTON (70709-013-03) / 3 mL in 1 SYRINGE, GLASS
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "98f58ca8-04a0-4453-adf0-b000d3bcfae1", "openfda": {"unii": ["325O8467XK"], "rxcui": ["1148141", "2569480"], "spl_set_id": ["1756aca0-21a1-4898-8d6c-9666738db45c"], "manufacturer_name": ["Cycle Pharmaceuticals Ltd-Uk"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE, GLASS in 1 CARTON (70709-013-01) / 3 mL in 1 SYRINGE, GLASS", "package_ndc": "70709-013-01", "marketing_start_date": "20210603"}, {"sample": false, "description": "3 SYRINGE, GLASS in 1 CARTON (70709-013-03) / 3 mL in 1 SYRINGE, GLASS", "package_ndc": "70709-013-03", "marketing_start_date": "20210603"}], "brand_name": "SAJAZIR", "product_id": "70709-013_98f58ca8-04a0-4453-adf0-b000d3bcfae1", "dosage_form": "INJECTION", "pharm_class": ["Bradykinin B2 Receptor Antagonist [EPC]", "Bradykinin B2 Receptor Antagonists [MoA]"], "product_ndc": "70709-013", "generic_name": "ICATIBANT", "labeler_name": "Cycle Pharmaceuticals Ltd-Uk", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "SAJAZIR", "active_ingredients": [{"name": "ICATIBANT ACETATE", "strength": "30 mg/3mL"}], "application_number": "ANDA212446", "marketing_category": "ANDA", "marketing_start_date": "20210603", "listing_expiration_date": "20261231"}